Russell Investments Group’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Russell Investments Group’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,913	Closed	-$38K	–	3014
2022 Q3	$38K	Sell	1,913 -104,188	-98%	-$1.37M	﹤0.01%	2766
2022 Q2	$730K	Buy	106,101 +87,827	+481%	+$616K	﹤0.01%	2100
2022 Q1	$169K	Buy	+18,274	New	+$195K	﹤0.01%	2492
2021 Q2	–	Sell	-15,540	Closed	-$435K	–	3344
2021 Q1	$435K	Sell	15,540 -9,535	-38%	-$344K	﹤0.01%	2582
2020 Q4	$881K	Buy	+25,075	New	+$1.09M	﹤0.01%	2171

Russell Investments Group's FMTX Position: Q4 2022 in Review

Russell Investments Group sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 1,913 shares — an estimated $38K sold.

Russell Investments Group first reported a position in FMTX in Q4 2020 and held it in 5 quarters. The position peaked at $881K in Q4 2020. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Russell Investments Group reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Russell Investments Group sold 1,913 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $38K.
Russell Investments Group first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
Russell Investments Group's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $881K in Q4 2020.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Russell Investments Group's 13F filing for Q4 2022, filed 8 Feb 2023.